OPTI OptiBiotix Health Plc

0.0639USD4.850 GBp · LSE0.00%Mkt Cap: 6.60M USDP/E: —

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifi…

Key Statistics

Company
Market Cap6.60M USD
Enterprise Value5.30M USD
Revenue (TTM)1.70M USD
Gross Profit808.54K USD
Net Income (TTM)-5.12M USD
Revenue/Share0.02 USD
Last Price0.0639 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees9
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB00BP0RTP38
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.79
EV/Revenue3.12
P/S3.89
P/B1.05
EPS (TTM)-0.05 USD
EPS (Forward)—
52W Range
0.05796% of range0.1613
52W High0.1613 USD
52W Low0.0579 USD
Profitability
Gross Margin52.66%
Oper. Margin-190.06%
EBITDA Margin-173.91%
Profit Margin-333.62%
ROE-61.92%
ROA-56.44%
ROIC—
ROCE-48.13%
Growth
Revenue Growth21.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.33M USD
CapEx (TTM)—
FCF Margin-61.41%
FCF Yield-15.79%
Net Debt-1.30M USD
Net Debt/EBITDA0.44
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio6.83
Quick Ratio5.23
Book Value/Sh0.06 USD
Cash/Share0.01 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:200
Split DateAug 5, 2014
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.103.30M
Float92.65M
Insiders11.35%
Institutions7.71%
Technical
SMA 500.0755 (-15.4%)
SMA 2000.0761 (-16.1%)
Beta1.75
S&P 52W Chg12.08%
Avg Vol (30d)124.44K
Avg Vol (10d)163.85K
Technical Indicators
RSI (14)36.1
MACD-0.2980
MACD Signal-0.2380
MACD Hist.-0.0601
BB Upper0.0833 USD
BB Middle0.0693 USD
BB Lower0.0552 USD
BB Width40.48%
ATR (14)0.0032 USD
Vol Ratio (20d)0.96x

About OptiBiotix Health (LON: OPTI)

›

OptiBiotix Health (LON: OPTI) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 9 employees.

The shares were at 4.850 GBp on 19 November 2026, down 57.8% over 52 weeks. Its 52-week range is 4.400 GBp to 12.25 GBp: the price is 60.4% below the high and 10.2% above the low.

Its market capitalisation is 5.01M GBP.

OptiBiotix Health reports return on equity of -61.9%, an operating margin of -190.1% and revenue up 21.9% year over year.

It holds more cash than debt, a net cash position of 989.00K GBP. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.